Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,243 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(61,038 products)
Found 205376 products of "Building Blocks"
rac-(1R,2S)-2-tert-Butylcyclohexane-1-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C11H20O2Purity:Min. 95%Molecular weight:184.3 g/mol5-[(2-Methylphenyl)amino]-1,3,4-thiadiazole-2-thiol
CAS:Versatile small molecule scaffoldFormula:C9H9N3S2Purity:Min. 95%Molecular weight:223.3 g/mol(Z)-3-(2-Phenylhydrazono)cyclohexanone
CAS:The method involves refluxing ethanol with a solid acid catalyst and a condensation agent. The reaction is catalyzed by the acid catalyst, which can be either an inorganic or organic acid. The reaction time is typically 3 to 4 hours. Effective catalysts include aluminum chloride, zinc chloride, and titanium tetrachloride. Carvedilol is an effective product of this reaction because it has a high yield and a low production cost. Solid-acid catalysts are used for this synthesis because they have excellent stability in the presence of water and air and can be easily recovered from the reaction mixture. The reactants are heated at reflux until the desired product is formed. This process is typically carried out using a reflux apparatus equipped with an efficient condenser and an ice bath to maintain the temperature below boiling point. The yields of the desired product are typically high, ranging from 80% to 95%.Formula:C12H14N2OPurity:Min. 95%Molecular weight:202.25 g/mol6-(Dimethylamino)hexan-2-ol
CAS:Versatile small molecule scaffold
Formula:C8H19NOPurity:Min. 95%Molecular weight:145.24 g/mol5-(Dimethylamino)pentan-1-ol
CAS:Versatile small molecule scaffoldFormula:C7H17NOPurity:Min. 95%Molecular weight:131.22 g/mol5-(Dimethylamino)pentan-2-ol
CAS:Versatile small molecule scaffold
Formula:C7H17NOPurity:Min. 95%Molecular weight:131.22 g/mol2-Amino-1-(3-methoxyphenyl)ethanol
CAS:Versatile small molecule scaffoldFormula:C9H13NO2Purity:Min. 95%Molecular weight:167.21 g/mol5-(Aminomethyl)-2,3-dihydro-1H-pyrazol-3-one dihydrochloride
CAS:Versatile small molecule scaffold
Formula:C4H9Cl2N3OPurity:Min. 95%Molecular weight:186.04 g/mol[(1R,2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexyl]methanol
CAS:Versatile small molecule scaffoldFormula:C11H22OPurity:Min. 95%Molecular weight:170.29 g/mol2H-1,2-Benzothiazin-3(4H)-one, 1,1-dioxide
CAS:2H-1,2-Benzothiazin-3(4H)-one, 1,1-dioxide is a benzothiazine derivative. It has been shown to inhibit the activity of the enzyme glutathione reductase and the production of reactive oxygen species in mouse erythrocytes.Formula:C8H7NO3SPurity:Min. 95%Molecular weight:197.21 g/mol1-Propylpiperidin-3-ol
CAS:Versatile small molecule scaffold
Formula:C8H17NOPurity:Min. 95%Molecular weight:143.23 g/mol(1-Propylpyrrolidin-2-yl)methanol
CAS:Versatile small molecule scaffoldFormula:C8H17NOPurity:Min. 95%Molecular weight:143.23 g/mol2-Butoxypyridine
CAS:2-Butoxypyridine is a hydrophobic, potent inducers of the cytochrome P450 system. It can be used as a substrate for molecular modeling studies and has been shown to react with chlorine atom in mass spectrometric studies. The reaction products are pyridine compounds that are chlorinating agents. The chlorination reaction rate can be controlled by various techniques such as temperature, solvent, and concentration.
Formula:C9H13NOPurity:Min. 95%Molecular weight:151.21 g/molEthyl 2-chloro-4-phenylbutanoate
CAS:Versatile small molecule scaffoldFormula:C12H15ClO2Purity:Min. 95%Molecular weight:226.7 g/mol1-benzylcyclopropane-1-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C11H12O2Purity:Min. 95%Molecular weight:176.21 g/mol1-[2-(Methylsulfanyl)phenyl]propan-2-one
CAS:Versatile small molecule scaffoldFormula:C10H12OSPurity:Min. 95%Molecular weight:180.27 g/mol4-Imino-3,4-dihydro-1H-2,3-benzothiazine-2,2-dione
CAS:Versatile small molecule scaffoldFormula:C8H8N2O2SPurity:Min. 95%Molecular weight:196.23 g/mol(2-Cyanophenyl)methanesulfonamide
CAS:Versatile small molecule scaffoldFormula:C8H8N2O2SPurity:Min. 95%Molecular weight:196.23 g/mol2-(Cyanomethyl)benzene-1-sulfonamide
CAS:Versatile small molecule scaffold
Formula:C8H8N2O2SPurity:Min. 95%Molecular weight:196.23 g/mol2-(Cyanomethyl)benzene-1-sulfonyl chloride
CAS:Versatile small molecule scaffoldFormula:C8H6ClNO2SPurity:Min. 95%Molecular weight:215.66 g/mol2-(Sulfamoylmethyl)benzamide
CAS:Versatile small molecule scaffold
Formula:C8H10N2O3SPurity:Min. 95%Molecular weight:214.24 g/mol2-(3-Phenyl-1,2,4-oxadiazol-5-yl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C10H8N2O3Purity:Min. 95%Molecular weight:204.18 g/mol3-Methyl-5-isoxazoleacetic acid methyl ester
CAS:Versatile small molecule scaffoldFormula:C7H9NO3Purity:Min. 95%Molecular weight:155.15 g/mol4,6-Dihydroxypyridine-2-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C6H5NO4Purity:Min. 95%Molecular weight:155.11 g/mol1-tert-Butylcyclohexane-1-carboxylic acid
CAS:1-tert-Butylcyclohexane-1-carboxylic acid is the product of the rearrangement and carbocationization of 1-tert-butylcyclohexane. It can be used to synthesize propanoic acid. The reaction mixture is heated for a few hours, and when cooled, gaseous cyclopropane is evolved. The cyclopropane is then trapped with sodium borohydride and hydrolyzed to form 1-tert-butylcyclohexane-1-carboxylic acid. This compound can also be obtained by the carboxylation of propene with carbon dioxide in the presence of a catalyst such as platinum oxide or Raney nickel. This produces an intermediate that undergoes rearrangement and protonation reactions to produce 1-tert butylcyclohexane carboxylic acid.
Formula:C11H20O2Purity:Min. 95%Molecular weight:184.27 g/mol1-Bromo-2-(2-chloroethyl)benzene
CAS:Versatile small molecule scaffoldFormula:C8H8BrClPurity:Min. 95%Molecular weight:219.5 g/molEthyl 5-chloro-4-hydroxy-8-methoxyquinoline-3-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H12ClNO4Purity:Min. 95%Molecular weight:281.69 g/mol3-Amino-5-chloropyridine-2-carboxamide
CAS:3-Amino-5-chloropyridine-2-carboxamide is a phosphoinositide (PI) analog that has been shown to inhibit the growth of cancer cells. It also inhibits the production of proteins, such as cyclin D1 and Bcl-xL, which are required for cancer cell proliferation. 3-Amino-5-chloropyridine-2-carboxamide has been shown to be effective in vivo in animal models and in vitro in human cancer cells. The compound has been shown to have no effect on normal cells, leading to a low level of toxicity. This drug can be used as an anticancer agent or as part of a combined therapy regimen with other chemotherapeutic agents.
Formula:C6H6ClN3OPurity:Min. 95%Molecular weight:171.58 g/mol5-(hydroxymethyl)-1-methyl-1,2-dihydropyridin-2-one
CAS:Versatile small molecule scaffoldFormula:C7H9NO2Purity:Min. 95%Molecular weight:139.15 g/molMethyl 2-ethenylbenzoate
CAS:Methyl 2-ethenylbenzoate is a synthetic product that is used in the synthesis of polymers. It is an organic compound that can be synthesized by electroreduction of methyl ester, bromostyrene and styrene. The yields obtained in this process are high, with a conversion rate of over 90%. Methyl 2-ethenylbenzoate can be produced by cyclic voltammetry and cyclic voltammetry. The parameters for both methods are similar, but cyclic voltammetry has greater sensitivity and selectivity. Electrolysis also plays an important role in the production of this product.Formula:C10H10O2Purity:Min. 95%Molecular weight:162.19 g/mol3-Oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C8H8N2O4SPurity:Min. 95%Molecular weight:228.23 g/molD-Cysteine ethyl ester hydrochloride
CAS:D-Cysteine ethyl ester hydrochloride is a water-soluble drug that can be used as an additive in food composition. It is used in pharmaceutical preparations to treat bowel disease, congestive heart, and inflammatory bowel disease. This drug has a vasodilatory effect and can be used to treat inflammatory diseases, such as infectious diseases. D-Cysteine ethyl ester hydrochloride is also used for the treatment of autoimmune diseases, such as pyrazole ring.END>Formula:C5H12ClNO2SPurity:Min. 95%Molecular weight:185.67 g/mol{Amino[(3,4-dihydroxyphenyl)sulfanyl]methylidene}azanium acetate
CAS:Controlled ProductVersatile small molecule scaffoldFormula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/mol1-(2-Aminophenyl)-2-methylpropan-1-one
CAS:Versatile small molecule scaffold
Formula:C10H13NOPurity:Min. 95%Molecular weight:163.22 g/mol2-(Isoquinolin-1-yl)acetonitrile
CAS:2-(Isoquinolin-1-yl)acetonitrile is a white crystalline solid that is soluble in organic solvents. It can be synthesized by reacting phosphorus oxychloride and vanadium chlorides with molybdenum or by reacting a primary amine with an enamine, followed by hydrolyzing the resulting acetal. This compound can also be made from lactams using molecular oxygen and catalytic amounts of acetals and dimethylformamide.Formula:C11H8N2Purity:Min. 95%Molecular weight:168.19 g/mol4,4-Dimethyl-1,2,3,4-tetrahydroisoquinolin-1-one
CAS:Versatile small molecule scaffoldFormula:C11H13NOPurity:Min. 95%Molecular weight:175.23 g/mol3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H11NO4Purity:Min. 95%Molecular weight:233.22 g/molBenzene-1,2-disulfonamide
CAS:Benzene-1,2-disulfonamide is a sulfonamide that inhibits bacterial enzymes. It is an inhibitor of carbonic anhydrase, a human enzyme that catalyzes the conversion of carbon dioxide and water to bicarbonate. Benzene-1,2-disulfonamide has been shown to inhibit the growth of bacteria in vitro. The compound also has been found to be effective against some types of cancer cells, including those which are resistant to platinum-based chemotherapy. Benzene-1,2-disulfonamide binds to the active site of the bacterial enzyme and blocks its activity. The drug's high potency against anaerobic bacteria may be due to its ability to bind with nitro groups on proteins such as tetrahydrofolate reductase and cytochrome c oxidase.
Formula:C6H8N2O4S2Purity:Min. 95%Molecular weight:236.3 g/mol1,8,10-Triazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8-tetraene
CAS:1,8,10-Triazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8-tetraene is a chemical compound that has been shown to have medicinal properties and is an organic solvent used in organic chemistry. It contains a benzene ring with maleimide groups on either side of the ring. This chemical has been shown to be an anesthetic and is also water-soluble. 1,8,10-Triazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8-tetraene can be used as an equimolar replacement for chloroform in the synthesis of certain drugs such as diazepam and lorazepam due to its similar properties to chloroform but it does not react with water or alcohols as easily as chloroform does.
Formula:C10H11N3Purity:Min. 95%Molecular weight:173.21 g/mol4,6-Dichloro-N-methyl-1,3,5-triazin-2-amine
CAS:Versatile small molecule scaffoldFormula:C4H4Cl2N4Purity:Min. 95%Molecular weight:179 g/mol1-(1,1-Dioxidotetrahydrothien-3-yl)-3-methyl-1H-pyrazol-5-amine
CAS:Versatile small molecule scaffoldFormula:C8H13N3O2SPurity:Min. 95%Molecular weight:215.27 g/molrac-Ethyl (1R,2S)-2-benzylcyclopropane-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H16O2Purity:Min. 95%Molecular weight:204.3 g/molrac-Ethyl (1R,2R)-2-benzylcyclopropane-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H16O2Purity:Min. 95%Molecular weight:204.3 g/mol1-(2-Methoxyphenyl)-3-methylbutan-2-one
CAS:Versatile small molecule scaffoldFormula:C12H16O2Purity:Min. 95%Molecular weight:192.25 g/mol(2E)-3-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)prop-2-enoic acid
CAS:Versatile small molecule scaffoldFormula:C14H14N2O2Purity:Min. 95%Molecular weight:242.27 g/mol(2E)-3-(1-Phenyl-1H-pyrazol-4-yl)prop-2-enoic acid
CAS:Versatile small molecule scaffold
Formula:C12H10N2O2Purity:Min. 95%Molecular weight:214.22 g/molrac-(4aR,9bS)-2,8-Dimethyl-1H,2H,3H,4H,4aH,5H,9bh-pyrido[4,3-b]indole
CAS:Dimebon is a drug that binds to dopamine receptors (D2 and D3) and inhibits locomotor activity in rats. It also has been found to be effective in the treatment of cancer-induced cachexia, as well as bowel disease. Dimebon is a hydrogenated form of rac-(4aR,9bS)-2,8-dimethyl-1H,2H,3H,4H,4aH,5H,9bh-pyrido[4,3-b]indole. The drug was originally synthesized in the Soviet Union for use as an antidepressant but was never marketed because it caused severe side effects such as tardive dyskinesia. Dimebon has been shown to cause neuronal death through inhibition of the growth factor BDNF and its receptor activity. It also blocks dopamine release from nerve cells in the striatum. Dimebon is water soluble and can be taken orally or injected intravenously.Formula:C13H18N2Purity:Min. 95%Molecular weight:202.3 g/mol1,2,3,4-Tetrahydroquinoline-2-carboxylic acid HCl
CAS:Versatile small molecule scaffoldFormula:C10H12ClNO2Purity:Min. 95%Molecular weight:213.66 g/mol4-Bromo-3-chloro-1H-pyrazole
CAS:Versatile small molecule scaffold
Formula:C3H2BrClN2Purity:Min. 95%Molecular weight:181.42 g/mol3-bromo-4-iodo-1H-pyrazole
CAS:Versatile small molecule scaffold
Formula:C3H2BrIN2Purity:Min. 95%Molecular weight:272.9 g/mol
